Meis Omran

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Surveillance adherence and clinical findings in children with confirmed or familial TP53 variants: the Swedish multicenter constitutional TP53 study (SWEP53).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 14, 2025

TP53 p.R181H is enriched in the Swedish cohort (SWEP53) and associated with a distinct breast and prostate phenotype.

TP53 p.R181H is enriched in the Swedish cohort (SWEP53) and associated with a distinct breast and prostate phenotype.

Journal: Scientific reports

Published: July 03, 2025

The argument for screening programs in previvors with Li-Fraumeni syndrome.

The argument for screening programs in previvors with Li-Fraumeni syndrome.

Journal: Expert review of anticancer therapy

Published: June 21, 2025

Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.

Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.

Journal: JMIR formative research

Published: March 23, 2025

Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant-is it too soon to draw conclusions?

Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant-is it too soon to draw conclusions?

Journal: Journal of the National Cancer Institute

Published: January 06, 2025

Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.

Journal: European journal of human genetics : EJHG

Published: February 28, 2024

Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.

Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study.

Journal: Cancer

Published: October 13, 2022

Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).

Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53).

Journal: Cancers

Published: December 08, 2021

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53.

Journal: Hereditary cancer in clinical practice

Published: October 19, 2019

Pharmacologic symptom relief at the end of life

Pharmacologic symptom relief at the end of life

Journal: Lakartidningen

Published: February 08, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026